SCHEMBL8901731

SCHEMBL8901731

CC(=O)Oc1c2c(cc3ccccc13)C(=O)C1=C(C[C@](C)(C(=O)O)O[C@H]1O)C2=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 3/20 0.35
ADORA2A P29274 3/20 0.35
ADORA1 P30542 3/20 0.35
ELANE P08246 1/20 0.33
BACE1 P56817 2/20 0.32
KDM4E B2RXH2 4/20 0.32
ALDH1A1 P00352 3/20 0.32
MAPT P10636 3/20 0.32
KMT2A Q03164 2/20 0.32
POLB P06746 1/20 0.32
GAA P10253 1/20 0.32
APEX1 P27695 1/20 0.32
RECQL P46063 1/20 0.32
BLM P54132 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
HTT P42858 2/20 0.32
PKM P14618 2/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8903534 0.86 ADORA3 (0.33) ADORA3ADORA2AADORA1ELANEBACE1
SCHEMBL8901807 0.85 NQO1 (0.38) KDM4EALDH1A1MAPTKMT2APOLB
SCHEMBL8903524 0.83 ADORA3 (0.33) ADORA3ADORA2AADORA1ELANEBACE1
SCHEMBL9755766 0.82 ADORA3 (0.31) ADORA3ADORA2AADORA1ELANEKDM4E
SCHEMBL8902945 0.82 NQO1 (0.38) KDM4EALDH1A1MAPTKMT2APOLB
SCHEMBL8903687 0.82 NQO1 (0.38) KDM4EALDH1A1MAPTKMT2APOLB
SCHEMBL8901780 0.79 ADORA3 (0.31) ADORA3ADORA2AADORA1ELANEKDM4E
SCHEMBL8901727 0.78 KDM4E (0.34) ADORA3ADORA2AADORA1ELANEKDM4E
SCHEMBL9522381 0.75 KDM4E (0.34) ADORA3ADORA2AADORA1ELANEKDM4E
SCHEMBL8903531 0.74 NR1D1 (0.33) ADORA3ADORA2AADORA1ELANEKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5593970-A ANTITUMOR AND ANTCARCINOGENIC AGENTS; TRETMENT OF CANCEROUS BONE MARROW BEFORE REGRAFTING BIOCHEM PHARMA INC. (CA) 1997-01-14 US disclosed